Jrsis Health Care Corporation JRSS

Q3 FY2024 · ended Sep 30, 2024 · Revenue $222,922, -55.2% YoY · Filed Dec 20, 2024

Jrsis Health Care Corporation (JRSS) files with the SEC under industry code 8060, Services-Hospitals. In Q3 of fiscal 2024, the quarter ended Sep 30, 2024, it reported revenue of $222,922 and a net loss of $188,146. Free cash flow was -$419,899. As of Sep 30, 2024 it held $1,372 in cash and investments and $1.3 million in total debt.

Revenue
$222,922
-55.2% vs year-ago quarter
Net income
$-188,146
-658.2% vs year-ago quarter
Operating cash flow
$-352,266
-291.3% vs year-ago quarter
Free cash flow
$-419,899
-365.1% vs year-ago quarter
EPS
$-0.00
-650.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
84.60M
+1349.4% vs year-ago quarter
Net cash
$-1.34M
Q3 FY2024
Operating margin
-19.5%
TTM

Company profile

Industry
Services-Hospitals (SIC 8060)
Listed as
JRSS (OTC)
Fiscal year ends
December 31
Incorporated in
FL
Headquarters
Wuguishan, Zhongshan City, China
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1597892

Other Services-Hospitals companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q3 FY2024
Sep 30, 2024
Q2 FY2024
Jun 30, 2024
Q1 FY2024
Mar 31, 2024
Q4 FY2023
Dec 31, 2023
Q3 FY2023
Sep 30, 2023
Revenue
$222,922
$597,396
$500,420
$2.2M
$497,361
Operating income
-$206,190
-$118,718
-$160,906
-$189,850
$51,011
Net income
-$188,146
-$102,435
-$145,356
-$54,043
$33,705
Diluted EPS
-$0.00
-$0.00
-$0.00
-$0.00
$0.00
Operating cash flow
-$352,266
-$268,858
-$204,937
$95,758
-$90,031
Free cash flow
-$419,899
-$433,691
—
$50,875
-$90,280
Total assets
$2.1M
$2.1M
$2.1M
$2.1M
$564,700
Total liabilities
$2.3M
$2.1M
$2.4M
$2.3M
$90,969
Stockholders' equity
-$197,594
-$7,401
-$259,933
-$137,406
$473,731
Cash and investments
$1,372
$445,902
$323,611
$118,114
$741
Total debt
$1.3M
$1.4M
$1.4M
$46,940
$6,705

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Dec 20, 2024 Sep 30, 2024
10-Q Quarterly report Sep 5, 2024 Jun 30, 2024
10-Q Quarterly report May 29, 2024 Mar 31, 2024
10-K Annual report Apr 26, 2024 Dec 31, 2023
8-K Current report
Auditor change
Apr 11, 2024 Dec 13, 2023
8-K Current report
Officer or director change
Dec 11, 2023 Dec 11, 2023

Source: SEC EDGAR filings. This is company-reported data, not investment advice.